Neighbourly Pharmacy Stock Price, News & Analysis (TSE:NBLY) C$17.63 -0.25 (-1.40%) (As of 12/4/2023 ET) Add Compare Share Share Today's RangeC$17.55▼C$17.8750-Day RangeC$12.12▼C$19.0952-Week RangeC$12.05▼C$25.50Volume31,524 shsAverage Volume55,164 shsMarket CapitalizationC$789.82 millionP/E RatioN/ADividend Yield1.02%Price TargetC$23.07 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlines About Neighbourly Pharmacy Stock (TSE:NBLY)Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.Read More NBLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NBLY Stock News HeadlinesNovember 15, 2023 | msn.comDown 20% in 8 Months, Is Neighbourly Pharmacy Stock a Buy Today?November 13, 2023 | marketwatch.comNeighbourly Pharmacy Shares Pull Back After Exclusivity Period With Suitor ExtendedDecember 5, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.November 13, 2023 | finance.yahoo.comNeighbourly Extends Exclusivity and Provides Update on Letter of Intent with Persistence Capital PartnersOctober 24, 2023 | finance.yahoo.comNeighbourly Announces Strong Second Quarter ResultsOctober 18, 2023 | finance.yahoo.comAn Intrinsic Calculation For Neighbourly Pharmacy Inc. (TSE:NBLY) Suggests It's 22% UndervaluedOctober 10, 2023 | finance.yahoo.comNeighbourly Announces Timing of Second Quarter 2024 Earnings ReleaseOctober 4, 2023 | markets.businessinsider.comBMO Capital Keeps a Hold Rating on Neighbourly Pharmacy, Inc. (NBLY)December 5, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 3, 2023 | theglobeandmail.comNeighbourly Pharmacy agrees to go-private offer from private-equity backerOctober 3, 2023 | msn.comNeighbourly Pharmacy Stock (TSE:NBLY) to Be Acquired; Stock Soars 60%October 3, 2023 | marketwatch.comNeighbourly Pharmacy Shares Jump 57% on Go-Private Agreement With Private Equity FirmOctober 3, 2023 | theglobeandmail.comNeighbourly Pharmacy signs deal with largest shareholder to go privateOctober 3, 2023 | finance.yahoo.comNeighbourly Enters into Letter of Intent to go Private with its Controlling Shareholder Persistence Capital PartnersOctober 2, 2023 | msn.com2 Defensive Stocks That Can Gain up to 128%, According to Bay StreetSeptember 29, 2023 | finance.yahoo.comNeighbourly Recognized as One of Canada's Top Growing Companies in the Globe and Mail's Fifth-Annual RankingSeptember 8, 2023 | finance.yahoo.comWhile individual investors own 27% of Neighbourly Pharmacy Inc. (TSE:NBLY), private equity firms are its largest shareholders with 50% ownershipSeptember 3, 2023 | ca.finance.yahoo.com2 Stocks That Could Beat a Bear MarketAugust 25, 2023 | theglobeandmail.comClosing Bell: Neighbourly Pharmacy Inc flat on Thursday (NBLY)August 5, 2023 | finance.yahoo.comNeighbourly Pharmacy (TSE:NBLY) Has Announced A Dividend Of CA$0.045August 3, 2023 | markets.businessinsider.comRBC Capital Maintains a Buy Rating on Neighbourly Pharmacy, Inc. (NBLY)August 2, 2023 | markets.businessinsider.comBMO Capital Keeps Their Hold Rating on Neighbourly Pharmacy, Inc. (NBLY)August 2, 2023 | finance.yahoo.comNeighbourly Announces Annual Meeting ResultsAugust 1, 2023 | finance.yahoo.comNeighbourly Announces Strong First Quarter ResultsJuly 25, 2023 | finance.yahoo.comNeighbourly Pharmacy Inc. (TSE:NBLY) Is About To Turn The CornerJuly 21, 2023 | finance.yahoo.comNBLY.TO - Neighbourly Pharmacy Inc.July 13, 2023 | markets.businessinsider.comRBC Capital Remains a Buy on Neighbourly Pharmacy, Inc. (NBLY)See More Headlines Receive NBLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 9/26 Dividend8/28/2023Dividend Payable9/26/2023Ex-Dividend for 12/19 Dividend11/20/2023Today12/04/2023Dividend Payable12/19/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE Industry Pharmaceutical Retailers Sub-IndustryN/A SectorMedical Current SymbolTSE:NBLY CUSIPN/A CIKN/A Webneighbourlypharmacy.ca Phone416 309 9102FaxN/AEmployees3,648Year FoundedN/APrice Target and Rating Average Stock Price TargetC$23.07 High Stock Price TargetC$28.00 Low Stock Price TargetC$20.00 Potential Upside/Downside+30.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.85) Trailing P/E RatioN/A Forward P/E Ratio25.03 P/E GrowthN/ANet IncomeC$-26,610,000.00 Net Margins-3.20% Pretax MarginN/A Return on Equity-5.46% Return on Assets0.94% Debt Debt-to-Equity Ratio56.99 Current Ratio1.15 Quick Ratio0.75 Sales & Book Value Annual SalesC$831.61 million Price / Sales0.95 Cash FlowC$0.57 per share Price / Cash Flow31.16 Book ValueC$13.19 per share Price / Book1.34Miscellaneous Outstanding Shares44,800,000Free FloatN/AMarket CapC$789.82 million OptionableNot Optionable Beta0.35 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Skip Bourdo (Age 46)CEO & Director Comp: $604.17kMr. Billy Wong C.M.A.CPA, M.B.A., Chief Financial OfficerMr. Jari Pekka Villanen (Age 52)Senior Vice President of Operations Comp: $307.48kMr. Roy J. Wieschkowski (Age 60)Senior Vice President of People & Culture Comp: $255.84kMr. Steve Losty (Age 49)Chief Development Officer Comp: $302.15kKey CompetitorsSienna Senior LivingTSE:SIAWELL Health TechnologiesTSE:WELLCanopy GrowthTSE:WEEDHydropothecaryCVE:THCXExtendicareTSE:EXEView All CompetitorsInsidersStephen Richard LostySold 22,767 sharesTotal: C$404,489.91 ($17.77/share)Stephen Richard LostySold 13,392 sharesTotal: C$307,608.88 ($22.97/share) NBLY Stock Analysis - Frequently Asked Questions Should I buy or sell Neighbourly Pharmacy stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NBLY shares. View NBLY analyst ratings or view top-rated stocks. What is Neighbourly Pharmacy's stock price target for 2024? 6 brokers have issued 12-month target prices for Neighbourly Pharmacy's stock. Their NBLY share price targets range from C$20.00 to C$28.00. On average, they anticipate the company's share price to reach C$23.07 in the next twelve months. This suggests a possible upside of 30.9% from the stock's current price. View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts. How have NBLY shares performed in 2023? Neighbourly Pharmacy's stock was trading at C$23.39 at the beginning of 2023. Since then, NBLY stock has decreased by 24.6% and is now trading at C$17.63. View the best growth stocks for 2023 here. How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy? Neighbourly Pharmacy announced a quarterly dividend on Monday, November 20th. Investors of record on Tuesday, December 19th will be paid a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend is Monday, November 20th. Read our dividend analysis for NBLY. Is Neighbourly Pharmacy a good dividend stock? Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 1.01%. Read our dividend analysis for NBLY. How do I buy shares of Neighbourly Pharmacy? Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NBLY) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neighbourly Pharmacy Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.